Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow in Infectious Diseases, Medicine, Duke University 1988 - 1991
  • Medical Resident, Medicine, Duke University 1985 - 1988
  • M.D., University of Utah 1985
• 

  Previous Appointments & Affiliations

  • Consulting Professor in the Department of Medicine, Medicine, Infectious Diseases, Medicine 2009 - 2019
  • Professor of Medicine, Medicine, Infectious Diseases, Medicine 2008
  • Associate Professor of Medicine, Medicine, Infectious Diseases, Medicine 2003 - 2008
  • Assistant Professor of Medicine, Medicine, Infectious Diseases, Medicine 1994 - 2003
  • Associate in the Department of Medicine, Medicine, Infectious Diseases, Medicine 1991 - 1993
• Recognition
• 

  Awards & Honors

  • Charles C. Shepard Science Award. US Centers for Disease Control. 2012
• Research
• 

  Selected Grants

  • International Clinical Trials Unit awarded by National Institutes of Health 2004 - 2009
  • TB Clinical Research: Training the Next Generation awarded by National Institutes of Health 2004 - 2008
  • Enhancing the U.S. Public Health System's Willingness and Capacity to Engage in Clinical Research awarded by National Institutes of Health 2004 - 2008
  • Genetic studies of human susceptibility to tuberculosis awarded by National Institutes of Health 2001 - 2007
  • Adult AIDS Clinical Trials Unit awarded by National Institutes of Health 1996 - 2006
  • same awarded by National Institutes of Health 1996 - 2003
  • same awarded by National Institutes of Health 1997 - 2003
  • North Carolina: A Rural Model For Life-Long Tb Education awarded by National Institutes of Health 1997 - 2002
  • Epidemiologic Research Studies of AIDS and HIV Infection awarded by National Institutes of Health 1998 - 2000
  • Adult Aids Clinical Trials Unit awarded by National Institutes of Health 1996 - 1999
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Liu, Yu-Hong, Shu Chen, Jing-Tao Gao, Yao Zhang, Kimberly Booher, Xiao-Fen Ding, Wei Shu, et al. “The China tuberculosis clinical trials consortium network: a model for international TB clinical trials capacity building.” Infect Dis Poverty 9, no. 1 (May 15, 2020): 52. https://doi.org/10.1186/s40249-020-00671-w.
       Full Text  Link to Item
    • Mao, Wenhui, Weixi Jiang, Carol Hamilton, Hui Zhang, Fei Huang, Henry Lucas, Shitong Huan, and Shenglan Tang. “Over- and under-treatment of TB patients in Eastern China: an analysis based on health insurance claims data.” Trop Med Int Health 24, no. 9 (September 2019): 1078–87. https://doi.org/10.1111/tmi.13287.
       Full Text  Link to Item
    • MacQueen, Kathleen M., Natalie T. Eley, Mike Frick, and Carol Hamilton. “Using theory of change frameworks to develop evaluation strategies for research engagement: results of a pre-pilot study.” J Int Aids Soc 21 Suppl 7 (October 2018): e25181. https://doi.org/10.1002/jia2.25181.
       Full Text  Link to Item
    • Auld, Andrew F., Ray W. Shiraishi, Ikwo Oboho, Christine Ross, Moses Bateganya, Valerie Pelletier, Jacob Dee, et al. “Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.” Mmwr Morb Mortal Wkly Rep 66, no. 21 (June 2, 2017): 558–63. https://doi.org/10.15585/mmwr.mm6621a3.
       Full Text  Link to Item
    • Moro, R. N., T. R. Sterling, J. Saukkonen, A. Vernon, C. R. Horsburgh, R. E. Chaisson, C. D. Hamilton, M. E. Villarino, and S. Goldberg. “Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.” Int J Tuberc Lung Dis 21, no. 3 (March 1, 2017): 286–96. https://doi.org/10.5588/ijtld.16.0469.
       Full Text  Link to Item
    • Mastro, Timothy D., Charles S. Morrison, and Carol Dukes Hamilton. “Determining the Incidence of Hepatitis C Virus Infection in Populations: An Important Tool for Epidemic Control.” J Infect Dis 214, no. 3 (August 1, 2016): 339–40. https://doi.org/10.1093/infdis/jiw006.
       Full Text  Link to Item
    • MacQueen, Kathleen M., Natalie T. Eley, Mike Frick, Laia Ruiz Mingote, Alicia Chou, Stephanie S. Seidel, Stacey Hannah, and Carol Hamilton. “Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials.” J Empir Res Hum Res Ethics 11, no. 3 (July 2016): 203–13. https://doi.org/10.1177/1556264616657452.
       Full Text  Link to Item
    • Holland, D. P., C. D. Hamilton, and J. E. Stout. “Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.” Int J Tuberc Lung Dis 20, no. 6 (June 2016): 827–31. https://doi.org/10.5588/ijtld.15.0006.
       Full Text  Link to Item
    • Cao, Bin, Hainv Gao, Boping Zhou, Xilong Deng, Chengping Hu, Chaosheng Deng, Hongzhou Lu, et al. “Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia.” Crit Care Med 44, no. 6 (June 2016): e318–28. https://doi.org/10.1097/CCM.0000000000001616.
       Full Text  Link to Item
    • Auld, Andrew F., Ray W. Shiraishi, Francisco Mbofana, Aleny Couto, Ernest Benny Fetogang, Shenaaz El-Halabi, Refeletswe Lebelonyane, et al. “Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013.” Mmwr Morb Mortal Wkly Rep 64, no. 46 (November 27, 2015): 1281–86. https://doi.org/10.15585/mmwr.mm6446a2.
       Full Text  Link to Item
    • Hamilton, Carol D., Soumya Swaminathan, Devasahayam J. Christopher, Jerrold Ellner, Amita Gupta, Timothy R. Sterling, Valeria Rolla, et al. “RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration.” Clin Infect Dis 61Suppl 3 (October 15, 2015): S155–59. https://doi.org/10.1093/cid/civ611.
       Full Text  Link to Item
    • Sterling, Timothy R., Ruth N. Moro, Andrey S. Borisov, Elizabeth Phillips, Gillian Shepherd, Newton Franklin Adkinson, Stephen Weis, Christine Ho, Margarita Elsa Villarino, and Margarita Elsa Tuberculosis Trials Consortium. “Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.” Clin Infect Dis 61, no. 4 (August 15, 2015): 527–35. https://doi.org/10.1093/cid/civ323.
       Full Text  Link to Item
    • McDowell, M., M. Hossain, N. Rahman, K. Tegenfeldt, N. Yasmin, M. G. Johnson, and C. D. Hamilton. “Expanding tuberculosis case notification among marginalized groups in Bangladesh through peer sputum collection.” Public Health Action 5, no. 2 (June 21, 2015): 119–21. https://doi.org/10.5588/pha.15.0014.
       Full Text  Link to Item
    • Auld, Andrew F., Simon G. Agolory, Ray W. Shiraishi, Fred Wabwire-Mangen, Gideon Kwesigabo, Modest Mulenga, Sebastian Hachizovu, et al. “Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013.” Mmwr Morb Mortal Wkly Rep 63, no. 47 (November 28, 2014): 1097–1103.
       Link to Item
    • Reves, R., C. M. Heilig, J. M. Tapy, L. Bozeman, R. P. Kyle, C. D. Hamilton, N. Bock, et al. “Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.” Int J Tuberc Lung Dis 18, no. 5 (May 2014): 571–80. https://doi.org/10.5588/ijtld.13.0304.
       Full Text  Link to Item
    • Reddy, E. A., B. N. Njau, S. C. Morpeth, K. E. Lancaster, A. C. Tribble, V. P. Maro, L. J. Msuya, et al. “A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania.” Bmc Infectious Diseases 14, no. 1 (February 20, 2014). https://doi.org/10.1186/1471-2334-14-89.
       Full Text
    • Reddy, Elizabeth A., Boniface N. Njau, Susan C. Morpeth, Kathryn E. Lancaster, Alison C. Tribble, Venance P. Maro, Levina J. Msuya, et al. “A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania.” Bmc Infect Dis 14 (February 20, 2014): 89. https://doi.org/10.1186/1471-2334-14-89.
       Full Text  Open Access Copy  Link to Item
    • Centers for Disease Control and Prevention (CDC), Margarita Elsa. “Differences between HIV-Infected men and women in antiretroviral therapy outcomes - six African countries, 2004-2012.” Mmwr Morb Mortal Wkly Rep 62, no. 47 (November 29, 2013): 945–52.
       Link to Item
    • Dooley, Kelly E., Carole Mitnick, Mary Ann Degroote, Ekwaro Obuku, Carol D. Hamilton, Mamodikoe Makhene, Sarita Shah, et al. “Reply to Seddon, Schaaf, and Hesseling.” Clin Infect Dis 56, no. 1 (January 2013): 168–69. https://doi.org/10.1093/cid/cis820.
       Full Text  Link to Item
    • Dooley, Kelly E., Carole D. Mitnick, Mary Ann DeGroote, Ekwaro Obuku, Vera Belitsky, Carol D. Hamilton, Mamodikoe Makhene, et al. “Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.” Clin Infect Dis 55, no. 4 (August 2012): 572–81. https://doi.org/10.1093/cid/cis487.
       Full Text  Link to Item
    • Nahid, Payam, Peter S. Kim, Carlton A. Evans, David Alland, Michael Barer, Jane Diefenbach, Jerrold Ellner, et al. “Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.” J Infect Dis 205 Suppl 2 (May 15, 2012): S159–68. https://doi.org/10.1093/infdis/jis194.
       Full Text  Link to Item
    • Holland, David P., Gillian D. Sanders, Carol D. Hamilton, and Jason E. Stout. “Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.” Plos One 7, no. 1 (2012): e30194. https://doi.org/10.1371/journal.pone.0030194.
       Full Text  Open Access Copy  Link to Item
    • Velez Edwards, Digna R., Alessandra Tacconelli, Christian Wejse, Philip C. Hill, Gerard A. J. Morris, Todd L. Edwards, John R. Gilbert, et al. “MCP1 SNPs and pulmonary tuberculosis in cohorts from West Africa, the USA and Argentina: lack of association or epistasis with IL12B polymorphisms.” Plos One 7, no. 2 (2012): e32275. https://doi.org/10.1371/journal.pone.0032275.
       Full Text  Link to Item
    • Sterling, Timothy R., M Elsa Villarino, Andrey S. Borisov, Nong Shang, Fred Gordin, Erin Bliven-Sizemore, Judith Hackman, et al. “Three months of rifapentine and isoniazid for latent tuberculosis infection.” N Engl J Med 365, no. 23 (December 8, 2011): 2155–66. https://doi.org/10.1056/NEJMoa1104875.
       Full Text  Link to Item
    • Glickman, Seth W., Adanma Ndubuizu, Kevin P. Weinfurt, Carol D. Hamilton, Lawrence T. Glickman, Kevin A. Schulman, and Charles B. Cairns. “Perspective: The case for research justice: inclusion of patients with limited English proficiency in clinical research.” Acad Med 86, no. 3 (March 2011): 389–93. https://doi.org/10.1097/ACM.0b013e318208289a.
       Full Text  Link to Item
    • Morris, Gerard A. J., Digna R Velez Edwards, Philip C. Hill, Christian Wejse, Cyrille Bisseye, Rikke Olesen, Todd L. Edwards, et al. “Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and Argentina.” Plos One 6, no. 2 (February 9, 2011): e16656. https://doi.org/10.1371/journal.pone.0016656.
       Full Text  Link to Item
    • Nguyen, L. T., C. D. Hamilton, Q. Xia, and J. E. Stout. “Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003.” Int J Tuberc Lung Dis 15, no. 2 (February 2011): 257–i.
       Link to Item
    • Holland, David P., Gillian D. Sanders, Carol D. Hamilton, and Jason E. Stout. “Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.” Plos One 6, no. 7 (2011): e22276. https://doi.org/10.1371/journal.pone.0022276.
       Full Text  Open Access Copy  Link to Item
    • Mayer, Kenneth H., and Carol Dukes Hamilton. “Synergistic pandemics: confronting the global HIV and tuberculosis epidemics.” Clin Infect Dis 50 Suppl 3 (May 15, 2010): S67–70. https://doi.org/10.1086/651475.
       Full Text  Open Access Copy  Link to Item
    • Stout, Jason E., Andrzej S. Kosinski, Carol Dukes Hamilton, Philip C. Goodman, Ann Mosher, Dick Menzies, Neil Schluger, Awal Khan, John L. Johnson, and John L. Tuberculosis Trials Consortium. “Effect of improving the quality of radiographic interpretation on the ability to predict pulmonary tuberculosis relapse.” Acad Radiol 17, no. 2 (February 2010): 157–62. https://doi.org/10.1016/j.acra.2009.08.013.
       Full Text  Link to Item
    • Nahm, M., A. Walden, B. McCourt, K. Pieper, E. Honeycutt, C. D. Hamilton, R. A. Harrington, et al. “Standardising clinical data elements.” International Journal of Functional Informatics and Personalised Medicine 3, no. 4 (January 1, 2010): 314–41. https://doi.org/10.1504/IJFIPM.2010.040213.
       Full Text
    • Velez, Digna Rosa, Christian Wejse, Martin E. Stryjewski, Eduardo Abbate, William F. Hulme, Jamie L. Myers, Rosa Estevan, et al. “Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans.” Hum Genet 127, no. 1 (January 2010): 65–73. https://doi.org/10.1007/s00439-009-0741-7.
       Full Text  Link to Item
    • Velez, Digna Rosa, William F. Hulme, Jamie L. Myers, J Brice Weinberg, Marc C. Levesque, Martin E. Stryjewski, Eduardo Abbate, et al. “NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans.” Hum Genet 126, no. 5 (November 2009): 643–53. https://doi.org/10.1007/s00439-009-0713-y.
       Full Text  Link to Item
    • Gadkowski, L Beth, Carol D. Hamilton, Myra Allen, Ellen R. Fortenberry, Julie Luffman, Elizabeth Zeringue, and Jason E. Stout. “HIV-specific health care utilization and mortality among tuberculosis/HIV coinfected persons.” Aids Patient Care Stds 23, no. 10 (October 2009): 845–51. https://doi.org/10.1089/apc.2009.0030.
       Full Text  Link to Item
    • Tribble, A. C., C. D. Hamilton, J. A. Crump, A. Mgonja, A. Mtalo, E. Ndanu, D. K. Itemba, et al. “Missed opportunities for diagnosis of tuberculosis and human immunodeficiency virus co-infection in Moshi, Tanzania.” Int J Tuberc Lung Dis 13, no. 10 (October 2009): 1260–66.
       Link to Item
    • Velez, D. R., W. F. Hulme, J. L. Myers, M. E. Stryjewski, E. Abbate, R. Estevan, S. G. Patillo, J. R. Gilbert, C. D. Hamilton, and W. K. Scott. “Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians.” Int J Tuberc Lung Dis 13, no. 9 (September 2009): 1068–76.
       Link to Item
    • Dorman, Susan E., John L. Johnson, Stefan Goldberg, Grace Muzanye, Nesri Padayatchi, Lorna Bozeman, Charles M. Heilig, et al. “Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.” Am J Respir Crit Care Med 180, no. 3 (August 1, 2009): 273–80. https://doi.org/10.1164/rccm.200901-0078OC.
       Full Text  Link to Item
    • Holland, David P., Gillian D. Sanders, Carol D. Hamilton, and Jason E. Stout. “Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.” Am J Respir Crit Care Med 179, no. 11 (June 1, 2009): 1055–60. https://doi.org/10.1164/rccm.200901-0153OC.
       Full Text  Link to Item
    • Fiske, C. T., C. D. Hamilton, and J. E. Stout. “Corrigendum to "Alcohol use and clinical manifestations of tuberculosis" [J Infect 57 (2008) 385-391].” Journal of Infection 58, no. 5 (May 1, 2009): 394. https://doi.org/10.1016/j.jinf.2009.02.016.
       Full Text
    • Fiske, Christina T., Carol D. Hamilton, and Jason E. Stout. “Alcohol use and clinical manifestations of tuberculosis.” J Infect 58, no. 5 (May 2009): 395–401. https://doi.org/10.1016/j.jinf.2009.02.015.
       Full Text  Link to Item
    • Holland, David P., Carol D. Hamilton, Amy C. Weintrob, John J. Engemann, Ellen R. Fortenberry, Charles A. Peloquin, and Jason E. Stout. “Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.” Pharmacotherapy 29, no. 5 (May 2009): 503–10. https://doi.org/10.1592/phco.29.5.503.
       Full Text  Link to Item
    • Mayer, Kenneth Hugh, and Carol Dukes Hamilton. “Distributing US health aid.” Jama 301, no. 13 (April 1, 2009): 1339–40. https://doi.org/10.1001/jama.2009.412.
       Full Text  Link to Item
    • Fiske, Christina T., Carol D. Hamilton, and Jason E. Stout. “Alcohol use and clinical manifestations of tuberculosis.” J Infect 57, no. 5 (November 2008): 385–91. https://doi.org/10.1016/j.jinf.2008.08.011.
       Full Text  Link to Item
    • Hamilton, C. D., J. E. Stout, P. C. Goodman, A. Mosher, R. Menzies, N. W. Schluger, A. Khan, J. L. Johnson, A. N. Vernon, and A. N. Tuberculosis Trials Consortium. “The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse.” Int J Tuberc Lung Dis 12, no. 9 (September 2008): 1059–64.
       Link to Item
    • Stout, Jason E., Gregory W. Hopkins, Jay R. McDonald, Anita Quinn, Carol D. Hamilton, L Barth Reller, and Richard Frothingham. “Association between 16S-23S internal transcribed spacer sequence groups of Mycobacterium avium complex and pulmonary disease.” J Clin Microbiol 46, no. 8 (August 2008): 2790–93. https://doi.org/10.1128/JCM.00719-08.
       Full Text  Link to Item
    • Kipp, Aaron M., Jason E. Stout, Carol Dukes Hamilton, and Annelies Van Rie. “Extrapulmonary tuberculosis, human immunodeficiency virus, and foreign birth in North Carolina, 1993 - 2006.” Bmc Public Health 8 (April 4, 2008): 107. https://doi.org/10.1186/1471-2458-8-107.
       Full Text  Open Access Copy  Link to Item
    • Dukes Hamilton, Carol, Timothy R. Sterling, Henry M. Blumberg, Michael Leonard, James McAuley, David Schlossberg, Jason Stout, and Gwen Huitt. “Extensively drug-resistant tuberculosis: are we learning from history or repeating it?” Clin Infect Dis 45, no. 3 (August 1, 2007): 338–42. https://doi.org/10.1086/519292.
       Full Text  Link to Item
    • Mitsuyasu, Ronald, Rebecca Gelman, Deborah Weng Cherng, Alan Landay, John Fahey, Richard Reichman, Alejo Erice, et al. “The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.” Arch Intern Med 167, no. 6 (March 26, 2007): 597–605. https://doi.org/10.1001/archinte.167.6.597.
       Full Text  Link to Item
    • Glickman, S. W., E. B. Rasiel, C. D. Hamilton, and K. A. Schulman. “Response [2].” Science 315, no. 5815 (February 23, 2007): 1076–77.
    • Glickman, Seth W., Emma B. Rasiel, Carol Dukes Hamilton, and Kevin A. Schulman. “Developing drugs for tuberculosis - Response.” Science 315, no. 5815 (February 23, 2007): 1076–77.
       Link to Item
    • McCourt, B., R. A. Harrington, K. Fox, C. D. Hamilton, K. Booher, W. E. Hammond, A. Walden, and M. Nahm. “Data standards: At the intersection of sites, clinical research networks, and standards development initiatives.” Drug Information Journal 41, no. 3 (January 1, 2007): 393–404. https://doi.org/10.1177/009286150704100313.
       Full Text
    • Stout, J. E., T. Ostbye, E. B. Walter, and C. D. Hamilton. “Tuberculosis knowledge and attitudes among physicians who treat young children in North Carolina, USA.” Int J Tuberc Lung Dis 10, no. 7 (July 2006): 783–88.
       Link to Item
    • Stout, Jason E., Kapil K. Saharia, Savithri Nageswaran, Amina Ahmed, and Carol Dukes Hamilton. “Racial and ethnic disparities in pediatric tuberculosis in North Carolina.” Arch Pediatr Adolesc Med 160, no. 6 (June 2006): 631–37. https://doi.org/10.1001/archpedi.160.6.631.
       Full Text  Link to Item
    • Glickman, Seth W., Emma B. Rasiel, Carol Dukes Hamilton, Arsen Kubataev, and Kevin A. Schulman. “Medicine. A portfolio model of drug development for tuberculosis.” Science 311, no. 5765 (March 3, 2006): 1246–47. https://doi.org/10.1126/science.1119299.
       Full Text  Link to Item
    • Frothingham, Richard, Jason E. Stout, and Carol Dukes Hamilton. “Current issues in global tuberculosis control.” Int J Infect Dis 9, no. 6 (November 2005): 297–311. https://doi.org/10.1016/j.ijid.2005.04.001.
       Full Text  Link to Item
    • Hamilton, Carol Dukes. “Immunosuppression related to collagen-vascular disease or its treatment.” Proc Am Thorac Soc 2, no. 5 (2005): 456–60. https://doi.org/10.1513/pats.200508-091JS.
       Full Text  Link to Item
    • Hamilton, Carol Dukes. “Infectious complications of treatment with biologic agents.” Curr Opin Rheumatol 16, no. 4 (July 2004): 393–98. https://doi.org/10.1097/01.bor.0000127594.92432.7c.
       Full Text  Link to Item
    • Stout, Jason E., John J. Engemann, and Carol D. Hamilton. “Tuberculosis transmission from a patient with skin lesions and a negative sputum smear.” N Engl J Med 350, no. 24 (June 10, 2004): 2527–28. https://doi.org/10.1056/NEJM200406103502423.
       Full Text  Link to Item
    • Hamilton, Carol Dukes. “Tuberculosis in the cytokine era: what rheumatologists need to know.” Arthritis Rheum 48, no. 8 (August 2003): 2085–91. https://doi.org/10.1002/art.11134.
       Full Text  Link to Item
    • Stout, Jason E., John J. Engemann, Allen C. Cheng, Ellen R. Fortenberry, and Carol D. Hamilton. “Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.” Am J Respir Crit Care Med 167, no. 6 (March 15, 2003): 824–27. https://doi.org/10.1164/rccm.200209-998OC.
       Full Text  Link to Item
    • Johnson, Melissa D., Carol D. Hamilton, Richard H. Drew, Linda L. Sanders, Gennethel J. Pennick, and John R. Perfect. “A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution.” J Antimicrob Chemother 51, no. 2 (February 2003): 453–57. https://doi.org/10.1093/jac/dkg089.
       Full Text  Link to Item
    • Stout, Jason E., James C. Lai, Julia Giner, and Carol Dukes Hamilton. “Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy.” Clin Infect Dis 35, no. 4 (August 15, 2002): e37–39. https://doi.org/10.1086/341306.
       Full Text  Link to Item
    • Bock, Naomi N., Timothy R. Sterling, Carol D. Hamilton, Connie Pachucki, Yong-Cheng Wang, Donna S. Conwell, Ann Mosher, Mary Samuels, Andrew Vernon, and Andrew Tuberculosis Trials Consortium, Centers for Disease Control and Prevention, Atlanta, Georgia. “A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.” Am J Respir Crit Care Med 165, no. 11 (June 1, 2002): 1526–30. https://doi.org/10.1164/rccm.200201-047OC.
       Full Text  Link to Item
    • Stout, Jason E., Raoult Ratard, Karen L. Southwick, and Carol Dukes Hamilton. “Epidemiology of human immunodeficiency virus testing among patients with tuberculosis in North Carolina.” South Med J 95, no. 2 (February 2002): 231–38.
       Link to Item
    • Alexander, B. D., J. E. Stout, L. B. Reller, and C. D. Hamilton. “Hospital management of tuberculosis in a region with a low incidence of tuberculosis and a high prevalence of nontuberculous mycobacteria.” Infect Control Hosp Epidemiol 22, no. 11 (November 2001): 715–17. https://doi.org/10.1086/501851.
       Full Text  Link to Item
    • McDonald, J. R., J. E. Stout, S. K. Sharps, and C. D. Hamilton. “Impact of highly active antiretroviral therapy on survival of patients with disseminated Mycobacterium avium in complex disease associated with late-stage human immunodeficiency virus infection.” Clinical Infectious Diseases 33, no. 7 (October 1, 2001): 1219–1219.
       Link to Item
    • Stout, J. E., C. W. Woods, A. A. Alvarez, A. Berchuck, and C. Dukes Hamilton. “Mycobacterium bovis peritonitis mimicking ovarian cancer in a young woman.” Clin Infect Dis 33, no. 4 (August 15, 2001): E14–16. https://doi.org/10.1086/321908.
       Full Text  Link to Item
    • Robbins, W. A., K. L. Witt, J. K. Haseman, D. B. Dunson, L. Troiani, M. S. Cohen, C. D. Hamilton, et al. “Antiretroviral therapy effects on genetic and morphologic end points in lymphocytes and sperm of men with human immunodeficiency virus infection.” J Infect Dis 184, no. 2 (July 15, 2001): 127–35. https://doi.org/10.1086/322002.
       Full Text  Link to Item
    • Johnson, V. A., C. J. Petropoulos, C. R. Woods, J. D. Hazelwood, N. T. Parkin, C. D. Hamilton, and S. A. Fiscus. “Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant.” J Infect Dis 183, no. 11 (June 1, 2001): 1688–93. https://doi.org/10.1086/320697.
       Full Text  Link to Item
    • Boggess, K. A., E. R. Myers, and C. D. Hamilton. “Antepartum or postpartum isoniazid treatment of latent tuberculosis infection.” Obstet Gynecol 96, no. 5 Pt 1 (November 2000): 757–62. https://doi.org/10.1016/s0029-7844(00)01039-5.
       Full Text  Link to Item
    • Stout, J. E., J. R. McDonald, J. J. Engemann, B. D. Alexander, and C. D. Hamilton. “Conditions associated with pulmonary non-tuberculous mycobacteria (NTM) in a tertiary care hospital in the Southeastern US.” Clinical Infectious Diseases 31, no. 1 (July 1, 2000): 311–311.
       Link to Item
    • Hamilton, C. D., R. Drew, S. W. Janning, J. K. Latour, and S. Hayward. “Excessive use of vancomycin: a successful intervention strategy at an academic medical center.” Infect Control Hosp Epidemiol 21, no. 1 (January 2000): 42–45. https://doi.org/10.1086/501703.
       Full Text  Link to Item
    • Dobs, A. S., J. Cofrancesco, W. E. Nolten, A. Danoff, R. Anderson, C. D. Hamilton, J. Feinberg, D. Seekins, B. Yangco, and F. Rhame. “The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection.” Am J Med 107, no. 2 (August 1999): 126–32. https://doi.org/10.1016/s0002-9343(99)00193-x.
       Full Text  Link to Item
    • Hamilton, C. D. “Recent Developments in Epidemiology, Treatment, and Diagnosis of Tuberculosis.” Curr Infect Dis Rep 1, no. 1 (April 1999): 80–88. https://doi.org/10.1007/s11908-999-0014-6.
       Full Text  Link to Item
    • Alexander, B. D., J. E. Stout, L. B. Reller, and C. D. Hamilton. “Hospital management of patients suspected of pulmonary TB in a high incidence area for MOTT.” American Journal of Respiratory and Critical Care Medicine 159, no. 3 (March 1, 1999): A304–A304.
       Link to Item
    • Fowler, V. G., C. D. Hamilton, and C. A. Ohl. “Clostridium septicum myonecrosis presenting as a parapharyngeal abscess in a patient with aplastic anemia.” Infection 26, no. 5 (September 1998): 309–10. https://doi.org/10.1007/BF02962255.
       Full Text  Link to Item
    • Anderson, N., R. Drew, S. Hayward, J. Perfect, and C. D. Hamilton. “A successful program to optimize use of Amphotericin B Lipid Complex (ABLC) at an academic medical center.” Clinical Infectious Diseases 25, no. 2 (December 1, 1997): 434.
    • Dukes Hamilton, C., R. Drew, S. Hayward, J. Kure, and S. Janning. “Improving clinician adherence to vancomycin-use guidelines: Results of a pharmacist-based strategy at an Academic Medical Center.” Clinical Infectious Diseases 25, no. 2 (December 1, 1997): 425.
    • Cegielski, P., and C. S. Dukes. “Pericardial effusion in AIDS.” Circulation 96, no. 6 (September 16, 1997): 2080–81.
       Link to Item
    • Dodge, R. T., S. Carr, and C. D. Hamilton. “A patient's guide to safer sex. Reducing the risk of HIV and other sexually transmitted diseases.” N C Med J 58, no. 2 (March 1997): 119–21.
       Link to Item
    • Cegielski, J. P., A. E. Msengi, C. S. Dukes, and M. M. Levine. “Pathogenic Escherichia coli in children with and without chronic diarrhea in Tanzania.” J Infect Dis 174, no. 3 (September 1996): 675–77. https://doi.org/10.1093/infdis/174.3.675.
       Full Text  Link to Item
    • Dukes, C. S., T. J. Matthews, D. M. Lambert, G. B. Dreyer, S. R. Petteway, and J. B. Weinberg. “Potent inhibition of HIV type 1 infection of mononuclear phagocytes by synthetic peptide analogs of HIV type 1 protease substrates.” Aids Res Hum Retroviruses 12, no. 9 (June 10, 1996): 777–82. https://doi.org/10.1089/aid.1996.12.777.
       Full Text  Link to Item
    • Roth, D. A., C. D. White, C. D. Hamilton, J. L. Hall, and W. C. Stanley. “Adrenergic desensitization in left ventricle from streptozotocin diabetic swine.” J Mol Cell Cardiol 27, no. 10 (October 1995): 2315–25. https://doi.org/10.1016/s0022-2828(95)91875-2.
       Full Text  Link to Item
    • Dukes, C. S., Y. Yu, E. D. Rivadeneira, D. L. Sauls, H. X. Liao, B. F. Haynes, and J. B. Weinberg. “Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism.” J Virol 69, no. 7 (July 1995): 4000–4005. https://doi.org/10.1128/JVI.69.7.4000-4005.1995.
       Full Text  Link to Item
    • Dukes, C. S., B. A. Turpin, and J. R. Atwood. “Hospice education about people with AIDS as terminally ill patients: coping with a new epidemic of death.” Am J Hosp Palliat Care 12, no. 1 (January 1995): 25–31. https://doi.org/10.1177/104990919501200111.
       Full Text  Link to Item
    • Cegielski, J. P., J. Lwakatare, C. S. Dukes, L. E. Lema, G. J. Lallinger, J. Kitinya, L. B. Reller, and F. Sheriff. “Tuberculous pericarditis in Tanzanian patients with and without HIV infection.” Tuber Lung Dis 75, no. 6 (December 1994): 429–34. https://doi.org/10.1016/0962-8479(94)90116-3.
       Full Text  Link to Item
    • Dukes, C. S., T. J. Matthews, E. D. Rivadeneira, and J. B. Weinberg. “Neopterin production by HIV-1-infected mononuclear phagocytes.” J Leukoc Biol 56, no. 5 (November 1994): 650–53. https://doi.org/10.1002/jlb.56.5.650.
       Full Text  Link to Item
    • Dukes, C. S., A. C. Street, J. F. Starling, and J. D. Hamilton. “Hepatitis B vaccination and booster in predialysis patients: a 4-year analysis.” Vaccine 11, no. 12 (September 1993): 1229–32. https://doi.org/10.1016/0264-410x(93)90047-2.
       Full Text  Link to Item
    • Dukes, C. S., T. J. Matthews, and J. B. Weinberg. “Human immunodeficiency virus type 1 infection of human monocytes and macrophages does not alter their ability to generate an oxidative burst.” J Infect Dis 168, no. 2 (August 1993): 459–62. https://doi.org/10.1093/infdis/168.2.459.
       Full Text  Link to Item
    • Cegielski, J. P., A. E. Msengi, C. S. Dukes, R. Mbise, R. Redding-Lallinger, J. N. Minjas, M. L. Wilson, J. Shao, and D. T. Durack. “Intestinal parasites and HIV infection in Tanzanian children with chronic diarrhea.” Aids 7, no. 2 (February 1993): 213–21. https://doi.org/10.1097/00002030-199302000-00009.
       Full Text  Link to Item
    • Dukes, C. S., J. Sugarman, J. P. Cegielski, G. J. Lallinger, and D. H. Mwakyusa. “Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.” Trop Geogr Med 44, no. 4 (October 1992): 308–11.
       Link to Item
    • Dukes, C. S., and J. R. Perfect. “Amphotericin B-induced malignant hypertensive episodes.” J Infect Dis 161, no. 3 (March 1990): 588. https://doi.org/10.1093/infdis/161.3.588.
       Full Text  Link to Item
    • Gleeson, J. M., C. S. Dukes, N. L. Elstad, I. F. Chan, and D. E. Wilson. “Effects of estrogen/progestin agents on plasma retinoids and chylomicron remnant metabolism.” Contraception 35, no. 1 (January 1987): 69–78. https://doi.org/10.1016/0010-7824(87)90052-7.
       Full Text  Link to Item

  • Conference Papers

    • Heijden, Yuri F. van der, Fareed Abdullah, Bruno B. Andrade, Jason R. Andrews, Devasahayam J. Christopher, Julio Croda, Heather Ewing, et al. “Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.” In Tuberculosis (Edinb), 113:153–62, 2018. https://doi.org/10.1016/j.tube.2018.09.009.
       Full Text  Link to Item
    • Geadas, Carolina, Sonia K. Stoszek, David Sherman, Bruno B. Andrade, Sudha Srinivasan, Carol D. Hamilton, and Jerrold Ellner. “Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.” In Tuberculosis (Edinburgh, Scotland), 102:55–67, 2017. https://doi.org/10.1016/j.tube.2016.11.006.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.